1. Home
  2. LEGN vs LW Comparison

LEGN vs LW Comparison

Compare LEGN & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • LW
  • Stock Information
  • Founded
  • LEGN 2014
  • LW 1950
  • Country
  • LEGN United States
  • LW United States
  • Employees
  • LEGN N/A
  • LW N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • LW Packaged Foods
  • Sector
  • LEGN Health Care
  • LW Consumer Staples
  • Exchange
  • LEGN Nasdaq
  • LW Nasdaq
  • Market Cap
  • LEGN 7.0B
  • LW 7.3B
  • IPO Year
  • LEGN 2020
  • LW N/A
  • Fundamental
  • Price
  • LEGN $27.78
  • LW $53.84
  • Analyst Decision
  • LEGN Strong Buy
  • LW Buy
  • Analyst Count
  • LEGN 13
  • LW 12
  • Target Price
  • LEGN $75.67
  • LW $71.08
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • LW 1.6M
  • Earning Date
  • LEGN 05-13-2025
  • LW 04-03-2025
  • Dividend Yield
  • LEGN N/A
  • LW 2.75%
  • EPS Growth
  • LEGN N/A
  • LW N/A
  • EPS
  • LEGN N/A
  • LW 2.55
  • Revenue
  • LEGN $728,303,000.00
  • LW $6,387,400,000.00
  • Revenue This Year
  • LEGN $65.96
  • LW $1.32
  • Revenue Next Year
  • LEGN $52.55
  • LW $1.19
  • P/E Ratio
  • LEGN N/A
  • LW $21.09
  • Revenue Growth
  • LEGN 112.46
  • LW N/A
  • 52 Week Low
  • LEGN $29.27
  • LW $47.90
  • 52 Week High
  • LEGN $60.87
  • LW $89.51
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.61
  • LW 57.51
  • Support Level
  • LEGN $30.25
  • LW $50.38
  • Resistance Level
  • LEGN $33.30
  • LW $52.45
  • Average True Range (ATR)
  • LEGN 1.78
  • LW 1.31
  • MACD
  • LEGN -0.57
  • LW 0.22
  • Stochastic Oscillator
  • LEGN 5.19
  • LW 99.72

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About LW Lamb Weston Holdings Inc.

Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 14% of fiscal 2024 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.

Share on Social Networks: